Murray particularly liked your circular figure, FTO to gene, pathways, biology to drugs and your hypothesis. Nice explanation of the value of combined cardio protective and cytotoxic synergy. Hopefully the results will prove this out.
- Forums
- ASX - By Stock
- RAC
- CPACS: Research, Results, Market Comparisons, and Valuations
CPACS: Research, Results, Market Comparisons, and Valuations, page-70
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.58 |
Change
-0.030(1.87%) |
Mkt cap ! $268.3M |
Open | High | Low | Value | Volume |
$1.61 | $1.65 | $1.57 | $220.4K | 137.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1992 | $1.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.61 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1992 | 1.575 |
1 | 1650 | 1.570 |
1 | 1000 | 1.565 |
1 | 224 | 1.560 |
1 | 20000 | 1.540 |
Price($) | Vol. | No. |
---|---|---|
1.605 | 2000 | 1 |
1.645 | 10000 | 1 |
1.650 | 9988 | 3 |
1.680 | 12136 | 1 |
1.690 | 585 | 1 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online